Comparison of ras activation in prostate carcinoma in Japanese and American men

Prostate

Volumn 30, Issue 1, 1997, Pages 53-57

  Konishi, Noboru ^a   Hiasa, Yoshio ^a   Tsuzuki, Toshihide ^a   Tao, Ming ^a   Enomoto, Takayuki ^b   Miller, Gary J ^c  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

mutation rates; population variations; prostate cancer; ras

Indexed keywords

PROTEIN P21;

ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; ENVIRONMENTAL FACTOR; GENE ACTIVATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JAPAN; MALE; ONCOGENE H RAS; ONCOGENE K RAS; ONCOGENE N RAS; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CARCINOMA; RACE DIFFERENCE; SINGLE STRAND CONFORMATION POLYMORPHISM; UNITED STATES;

ADENOCARCINOMA; ASIAN CONTINENTAL ANCESTRY GROUP; DNA, NEOPLASM; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, RAS; HUMANS; IMMUNOHISTOCHEMISTRY; JAPAN; MALE; MUTATION; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS; RAS PROTEINS; UNITED STATES;

EID: 0031018463     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19970101)30:1<53::AID-PROS8>3.0.CO;2-M     Document Type: Article

References (23)

1. Tominaga Y, Aoki K, Hanai A, Kunihara N: Cancer statistics in Japan. Incidence/mortality/prognosis. Shinohara Shuppan Tokyo, 1993.
2. Franks LM: Proceedings: Etiology, epidemiology, and pathology of prostatic cancer. Cancer 32:1092-1095, 1973.
3. Bookstein R, MacGrogan D, Hilsenbeck SG, Sharkey F, Allred DC: p53 is mutated in a subset of advanced-stage prostate cancers. Cancer Res 53:3369-3373, 1993.
4. Navone NM, Troncoso P, Pisters LL, Goodrow TL, Palmer JL, Nichols WW, von Eschenbach AC, Conti CJ: p53 protein accumulation and gene mutation in the progression of human prostate carcinoma. J Natl Cancer Inst 85:1657-1669, 1993.
5. Peehl DM: Oncogenes in prostate cancer. An update. Cancer 71:1159-1164, 1993.
6. Carter BS, Epstein JI, Isaacs WB: ras gene mutations in human prostate cancer. Cancer Res 50:6830-6832, 1990.
7. Gumerlock PH, Poonamallee UR, Meyers FJ, deVere White RW: Activated ras alleles in human carcinoma of the prostate are rare. Cancer Res 51:1632-1637, 1991.
8. Moul JW, Friedrichs PA, Lance RS, Theune SM, Chang EH: Infrequent ras oncogene mutations in human prostate cancer. Prostate 20:327-328, 1992.
9. Konishi N, Enomoto T, Buzard G, Ohshima M, Ward JM, Rice JM: K-ras activation and ras p21 expression in latent prostatic carcinoma in Japanese men. Cancer 69: 2293-2299, 1992.
10. Anwar K, Nakakuki K, Shiraishi T, Naiki H, Yatani R, Inuzaka M: Presence of ras oncogene mutations and human papillomavirus DNA in human prostate carcinomas. Cancer Res 52:5991-5996, 1992.
11. Suzuki H, Aida S, Akimoto S, Igarashi T, Yatani R, Shimazaki J: State of adenomatous polyposis coli gene and ras oncogenes in Japanese prostate cancer. Jpn J Cancer Res 85:847-852, 1994.
12. Watanabe M, Shiraishi T, Yatani R, Nomura AMY, Stemmerman GN: International comparison on ras gene mutations in latent prostate carcinoma. Int J Cancer 58:174-178, 1994.
13. Gleason DF and the Veterans Administration Cooperative Urological Research Group: Histologic grading and clinical staging of prostatic carcinoma. In Tannenbaum M (ed): "Urologic Pathology: The Prostate." Philadelphia: Lea & Febiger, 1977, pp 35-46.
14. Suzuki Y, Orita M, Shiraishi M, Hayashi K, Sekiya T: Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene 5:1037-1043, 1990.
15. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T: Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphism. Proc Natl Acad Sci USA 86:2766-2770, 1989.
16. Sanger F, Nicklen S, Coulson AR: DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5463-5467, 1977.
17. Zaridze DG, Boyle P: Cancer of the prostate: Epidemiology and aetiology. Br J Urol 59:493-502, 1987.
18. Yatani R, Kusano I, Shiraishi T, Hayashi T, Stemmermann GN: Latent prostatic carcinoma: Pathological and epidemiological aspects. Jpn J Clin Oncol 19:319-326, 1989.
19. Yatani R, Shiraishi T, Nakakuki K, Kusano I, Takanari H, Hayashi T, Stemmermann GN: Trends in frequency of latent prostate carcinoma in Japan from 1965-1979 to 1982-1986. J Natl Cancer Inst 80:683-687, 1988.
20. Burmer GC, Loeb LA: Mutations in the KRAS2 oncogene during progressive stage of human colon carcinoma. Proc Natl Acad USA 86:2403-2407, 1989.
21. Enomoto T, Inoue M, Perantoni AO, Terakawa N, Tanizawa O, Rice JM: K-ras activation in neoplasms of the human female reproductive tract. Cancer Res 50:6139-6145, 1990.
22. Watanabe M, Ushijima T, Kakiuchi H, Shiraishi T, Yatani R, Shimazaki J, Kotake T, Sugimura T, Nagao M: p53 gene mutations in human prostate cancers in Japan: Different mutation spectra between Japan and Western countries. Jpn J Cancer Res 85:904-910, 1994.
23. Konishi N, Hiasa Y, Hayashi I, Matsuda H, Tsuzuki T, Tao M, Katahori Y, Shiraishi T, Yatani R, Shimazaki J: p53 mutations occur in clinical, but not latent, human prostate carcinoma. Jpn J Cancer Res 86:57-63, 1995.